Gentian Diagnostics (Norway) Market Value
| GENT Stock | NOK 58.60 0.20 0.34% |
| Symbol | Gentian |
Gentian Diagnostics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Gentian Diagnostics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Gentian Diagnostics.
| 12/19/2025 |
| 01/18/2026 |
If you would invest 0.00 in Gentian Diagnostics on December 19, 2025 and sell it all today you would earn a total of 0.00 from holding Gentian Diagnostics AS or generate 0.0% return on investment in Gentian Diagnostics over 30 days. Gentian Diagnostics is related to or competes with Hofseth Biocare, Navamedic ASA, Lifecare, ContextVision, and Arctic Bioscience. Gentian Diagnostics AS researches, develops, and produces biochemical reagents for use in medical diagnostics and resear... More
Gentian Diagnostics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Gentian Diagnostics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Gentian Diagnostics AS upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.81 | |||
| Information Ratio | 0.0343 | |||
| Maximum Drawdown | 9.68 | |||
| Value At Risk | (2.86) | |||
| Potential Upside | 4.03 |
Gentian Diagnostics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Gentian Diagnostics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Gentian Diagnostics' standard deviation. In reality, there are many statistical measures that can use Gentian Diagnostics historical prices to predict the future Gentian Diagnostics' volatility.| Risk Adjusted Performance | 0.0621 | |||
| Jensen Alpha | 0.194 | |||
| Total Risk Alpha | (0.12) | |||
| Sortino Ratio | 0.0419 | |||
| Treynor Ratio | (0.54) |
Gentian Diagnostics Backtested Returns
As of now, Gentian Stock is very steady. Gentian Diagnostics holds Efficiency (Sharpe) Ratio of 0.0475, which attests that the entity had a 0.0475 % return per unit of risk over the last 3 months. We have found thirty technical indicators for Gentian Diagnostics, which you can use to evaluate the volatility of the firm. Please check out Gentian Diagnostics' Risk Adjusted Performance of 0.0621, market risk adjusted performance of (0.53), and Downside Deviation of 1.81 to validate if the risk estimate we provide is consistent with the expected return of 0.1%. Gentian Diagnostics has a performance score of 3 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of -0.31, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Gentian Diagnostics are expected to decrease at a much lower rate. During the bear market, Gentian Diagnostics is likely to outperform the market. Gentian Diagnostics right now retains a risk of 2.17%. Please check out Gentian Diagnostics total risk alpha, treynor ratio, and the relationship between the jensen alpha and sortino ratio , to decide if Gentian Diagnostics will be following its current trending patterns.
Auto-correlation | 0.11 |
Insignificant predictability
Gentian Diagnostics AS has insignificant predictability. Overlapping area represents the amount of predictability between Gentian Diagnostics time series from 19th of December 2025 to 3rd of January 2026 and 3rd of January 2026 to 18th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Gentian Diagnostics price movement. The serial correlation of 0.11 indicates that less than 11.0% of current Gentian Diagnostics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.11 | |
| Spearman Rank Test | -0.04 | |
| Residual Average | 0.0 | |
| Price Variance | 0.41 |
Gentian Diagnostics lagged returns against current returns
Autocorrelation, which is Gentian Diagnostics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Gentian Diagnostics' stock expected returns. We can calculate the autocorrelation of Gentian Diagnostics returns to help us make a trade decision. For example, suppose you find that Gentian Diagnostics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Gentian Diagnostics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Gentian Diagnostics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Gentian Diagnostics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Gentian Diagnostics stock over time.
Current vs Lagged Prices |
| Timeline |
Gentian Diagnostics Lagged Returns
When evaluating Gentian Diagnostics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Gentian Diagnostics stock have on its future price. Gentian Diagnostics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Gentian Diagnostics autocorrelation shows the relationship between Gentian Diagnostics stock current value and its past values and can show if there is a momentum factor associated with investing in Gentian Diagnostics AS.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetOther Information on Investing in Gentian Stock
Gentian Diagnostics financial ratios help investors to determine whether Gentian Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Gentian with respect to the benefits of owning Gentian Diagnostics security.